Relative risk of breast cancer for high prolactin-increasing antipsychotic users, compared to non-prolactin-increasing antipsychotic users, we report calibrated hazard ratios (HRs) and their 95% confidence intervals (CIs) and p-value (P), with propensity score (PS) stratification or matching. This evidence concerns the gene PRL and breast carcinoma.